Results 41 to 50 of about 1,971,842 (244)

Fixed drug eruption related to fluconazole [PDF]

open access: yes, 2016
Fixed drug eruption (FDE) is a type of cutaneous drug reaction that occurs at the same sites upon re-exposure to specific medications.
Hsu, Sylvia   +4 more
core   +1 more source

A Pragmatic Trial of a Shared Decision‐Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ‐SAFE Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Hydroxychloroquine (HCQ) nonadherence in systemic lupus erythematosus (SLE) stemming from decision complexities can be improved with shared decision‐making (SDM) tools clarifying benefits and harms. This study aimed to develop and evaluate HCQ‐SAFE, a pictogram‐based SDM tool during SLE visits.
Caroline Packee   +8 more
wiley   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Acneiform drug eruption from pirfenidone [PDF]

open access: yesJAAD Case Reports
Jordyn Puccio, BS   +3 more
doaj   +2 more sources

Evaluating a virtual paediatric adverse drug reaction clinic

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck   +2 more
wiley   +1 more source

EXANTHEMATOUS DRUG ERUPTION [PDF]

open access: yes, 2023
                Dilaporkan kasus seorang wanita berusia 53 tahun, didiagnosis sebagai drug eruption.
Topik, M. Mimbar, Muzainy, Nurhafizah
core   +1 more source

Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014)

open access: yesDermatology Research and Practice, 2015
Background. Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed
Hossein Kavoussi   +6 more
doaj   +1 more source

A Probable Case of Mucosal Fixed Drug Eruption Following Treatment with Silodosin

open access: yesSultan Qaboos University Medical Journal, 2018
A fixed drug eruption consists of erythematous patches that appear on the skin and/or mucous membranes following administration of a drug which, once healed, leaves residual hyperpigmentation.
Eleni Klimi
doaj   +1 more source

Ixekizumab‐induced urticarial drug eruption

open access: yesSkin Health and Disease, 2023
Biological agents targeting inflammatory skin diseases have dramatically overcome many of the limitations of older oral therapeutic options. Among the various biological agents, ixekizumab is a humanised monoclonal antibody that blocks the biological ...
Ayaka Kaneoka   +3 more
doaj   +1 more source

Multifocal Bullous Fixed Drug Eruption

open access: yesActa Médica Portuguesa, 2022
N/a.
Carolina Oliveira   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy